STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Wor.Bul.Pub.Helt. 2023;18:9-14. Accessed February 3, 2026. https://scholarexpress.net/index.php/wbph/article/view/1965